Net Income

The market for at-home NAD+ therapy is booming, but as telehealth offers new convenience, it faces a wave of regulatory and safety questions.

Replimune halts a promising cancer therapy and cuts jobs after a stunning FDA rejection, citing a 'failed' system and inconsistent regulatory process.

Allogene Therapeutics faces a make-or-break moment as it prepares to unveil crucial trial data for its 'off-the-shelf' cancer therapy, cema-cel.

A jury found Abbott's Similac caused a fatal gut disease in premature infants, igniting a legal firestorm over what the formula giant knew and when.

A Chicago jury found Abbott liable for infants' injuries from Similac, adding to a wave of lawsuits over the deadly intestinal disease NEC.

Gensler's Andy Cohen joins the REIT's board, signaling a strategic shift toward design-led development in LA and Honolulu's premium real estate markets.

After sweeping awards, 'The Ebony Canal' takes its powerful message on Black maternal health from Hollywood to a global stage, aiming for systemic change.

With revenue soaring 265%, Primior Holdings' bet on its GAIA blockchain platform is paying off, bridging real estate with the future of digital assets.

In a major strategic coup, Barnes & Thornburg acquires an elite 12-lawyer insurance group, creating a national powerhouse and shaking up the legal market.

A hidden danger in IV lines causes thousands of preventable deaths. Now, one company is showcasing a new strategy to protect patients from this 'gross gap'.

The diagnostics firm posts strong 2025 growth, but the impending loss of a key partner puts its high-stakes strategic pivot squarely to the test.

IM Cannabis has 180 days to raise its stock price above $1.00 or risk delisting from Nasdaq, highlighting broader struggles in the global cannabis sector.

The deal with Sample Healthcare signals a major shift from managing data to using AI to execute revenue cycle tasks, tackling costs and staffing shortages.

Lead Real Estate’s ENT TERRACE hotels secure prestigious Booking.com awards, reflecting a successful strategy in Japan's booming extended-stay market.

As pet owners seek unique items, advanced laser engravers are empowering a new wave of entrepreneurs to tap into a multi-billion dollar market.

Amaero's major titanium powder agreement signals a massive production boost, aiming to strengthen the US supply chain for defense and aerospace industries.

The passing of Gordon Bowerman, Yangarra's chairman for over two decades, leaves a legacy of growth and a critical question of succession for the company.

Following a $600M all-stock acquisition, security firm Concorde International embraces a new identity, YOOV, signaling a bold pivot into AI.

Orvana Minerals targets European investors at key conferences as it navigates widening losses and seeks to capitalize on strong commodity markets.

Mazda names Continental Battery Systems its nationwide partner, a strategic move to streamline dealer supply and enhance service in the growing aftermarket.